NCT06209736Phase 2Terminated

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Study sponsor: Omeros Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04-14Actual
Enrollment · participants3Actual
Source updated2026-11-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 20 participants (planned). After: 3 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jan 2026. After: 14 Apr 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview